10 High Growth European Stocks To Buy

Page 3 of 10

8. BioNTech SE (NASDAQ:BNTX)

5-Year Revenue Growth Rate: 89.57%

Number of Hedge Fund Holders: 24

BioNTech SE (NASDAQ:BNTX) ranks among the best high growth European stocks to buy. On January 16, Goldman Sachs upgraded BioNTech SE (NASDAQ:BNTX) from Neutral to Buy and boosted its price target from $115 to $142, highlighting the company’s key position in oncology. According to the firm, BioNTech SE (NASDAQ:BNTX) stands “at the nexus of significant developments occurring in the oncology field,” particularly in next-generation immuno-oncology and antibody-drug conjugates (ADCs).

Goldman Sachs noted BioNTech’s extensive portfolio of programs aimed at an estimated market worth more than $100 billion, with key results coming in 2026 that could position the company as a pioneer in the next stage of oncology treatments.

However, Goldman Sachs recognized potential rivalry in BioNTech’s clinical development domains, including competition from other bispecific antibody companies and late-stage ADC initiatives. However, it determined that BioNTech has a “unique risk/reward opportunity” in the rapidly changing oncology field.

BioNTech SE (NASDAQ:BNTX) is a German biotechnology company that develops and commercializes novel immunotherapies and vaccines for cancer and infectious diseases.

Page 3 of 10